| Fund ID | 805-2750043547 |
| Fund type | Venture Capital Fund |
| 3(c)(1) exclusion | Yes |
| 3(c)(7) exclusion | No |
| Master fund | No |
| Feeder fund | No |
| Fund of funds | No |
| Relies on exemption from registration | Yes |
| Annual audit | Yes |
| Prepared per GAAP | Yes |
| Sub-advised | No |
| Sales limited to qualified investors | Yes |
| % of assets independently valued | 99% |
| Owned by the adviser or related persons | 20% |
| Owned by funds of funds | 0% |
| Owned by non-U.S. persons | 27% |
| Fund | Type | Gross assets |
|---|---|---|
| Special Situations Fund III Qp, L.P. | Hedge | $528.5M |
| Special Situations Technology Fund II, L.P. | Hedge | $190.9M |
| Special Situations Cayman Fund, L.P. | Hedge | $148.1M |
Life Sciences Innovation Fund, L.P. reports $5 million in gross assets, among the top 84% of private funds by size.
The stated minimum investment is $100,000.
Life Sciences Innovation Fund, L.P. is managed by Awm Investment Company Inc.
No. Private funds are not required to publicly disclose performance. Form ADV reports assets, structure, and service providers.